SEC Form 4 · accession 0000899243-18-031227
CONSTELLATION PHARMACEUTICALS INC · CNST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian Senderowicz
Officer — Chief Medical Officer
Period of report
Dec 13, 2018
Accepted (ET)
Dec 17, 2018 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 13, 2018 | M | 9,083 | $5.51 | A | 9,083 | D | |
| Common Stock | Dec 13, 2018 | M | 6,801 | $5.51 | A | 15,884 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.51 | Dec 13, 2018 | M | 9,083 | D | — | Jul 10, 2027 | Common Stock | 9,083 | 136,252 | D |
| Stock Option (right to buy)F2 | $5.51 | Dec 13, 2018 | M | 6,801 | D | — | Jul 10, 2027 | Common Stock | 6,801 | 65,866 | D |
Explanation of responses
- F1This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the option as of July 10, 2018 with the remainder vesting quarterly through July 10, 2021.
- F2This option was granted on July 11, 2017, and is schedule to vest (i) as to 9,083 shares underlying the option in equal quarterly installments from July 10, 2017 through July 10, 2021 and (ii) as to 63,584 shares underlying the option in equal quarterly installments from July 19, 2018 through July 19, 2022.